Photon Biosciences is a cutting-edge biotechnology company based in Spokane Valley, Washington. They are revolutionizing the field of diagnostic testing and disease prevention by developing a portable Dx platform, PBSDx, that delivers faster and more accurate test results than traditional laboratory methods. Equipped with advanced AI machine learning algorithms, next-generation imaging molecules, and optics, PBSDx is designed to provide accessible and on-the-go testing for individuals to take control of their health.
With their first-generation platform, PBSDx v2, already available, Photon Biosciences is actively developing a diverse portfolio of diagnostic tests for both human and veterinary applications. Their innovative solutions include the PBSHeartSafe test, which offers cost-effective and accurate measurements with predictive capabilities for diagnosing heart failure, and the PBSBactiSafe test, which detects bacterial contamination in blood platelets to prevent transfusion-related sepsis. By leveraging their expertise in biotechnology and collaboration with commercial, academic, and government partners, Photon Biosciences is committed to improving human and animal health through their groundbreaking diagnostic technologies.
Generated from the website